Medical Treatments for Prostate CancerThere are many different medical treatments for prostate cancer that involve the clinical care of a healthcare professional. These treatments include expectant therapy, surgery, radiation therapy, hormone therapy, and chemotherapy. Expectant therapy is to carefully observe and monitor the prostate cancer. Because prostate cancer cells often spread very slowly, many older men who have the disease may not need more extensive treatment. However, expectant therapy usually includes routine physician examinations, including digital rectal exams and PSA tests. The different types of surgery for prostate cancer are radical prostatectomy - an open-surgery procedure in which the entire prostate gland and surrounding tissue are removed. Transurethral resection of the prostate (TURP) - surgery to remove part of the prostate gland that surrounds the urethra. Cryosurgery - this procedure involves killing the cancer cells by freezing them with a small metal tool placed in the tumor. Side effects of prostate cancer surgery include incontinence and impotence. Incontinence is the inability to control urine and may result in dribbling of urine, especially immediately after surgery. Normal control usually returns within weeks or months after surgery. Impotence is the inability to achieve an erection. For a month, or so, after surgery, most men are not able to get an erection. Eventually, approximately 40 to 60 percent of men will be able to get an erection sufficient for sexual intercourse, but without ejaculation of semen, since removal of the prostate gland prevents that process.Radiation therapy uses high energy rays to kill or shrink cancer cells, and to decrease their ability to divide. Radiation is often used to treat prostate cancer that is still confined to the prostate gland, or has spread only to nearby tissue. If the disease is advanced, radiation may be used to reduce the size of the tumor and to provide relief from symptoms. Possible side effects of radiation for prostate cancer may include diarrhea, with or without blood in the stool, and colitis, problems associated with urination, a degree of impotence (inability to get an erection), which may occur within two years of radiation therapy. The goal of hormone therapy is to lower the level of male hormones in the body, particularly testosterone. Hormone therapy does not cure the cancer, and is often used to treat persons whose cancer has spread or recurred after treatment. Produced mainly in the testicles, testosterone causes prostate cancer cells to grow. Thus, reduced testosterone levels can make the prostate cancer shrink and become less active. Most studies show that hormone therapy works better if it is started early. Chemotherapy is the use of powerful, anti-cancer medications to kill cancer cells.. Hospitalization may be needed to monitor treatment and chemotherapy's side effects. Common side effects of chemotherapy include: nausea and vomiting, hair loss, anemia, reduced ability of blood to clot, mouth sores, increased likelihood of developing infections, fatigue. Most side effects disappear once treatment is stopped. |
| immune prostate cancer |
|
Harnessing the Immune system: | Prostate Cancer Research Institute This is another summary of a talk that will be presented at The 2007 National Conference on Prostate Cancer in Los Angeles, CA, September 7-9, 2007. AFAR: Immune Therapy for Prostate Cancer They tied a protective protein from the immune cells known as T cells to an antibody to PSA. They tested this combination in prostate cancer cells in Common Molecule Notifies Immune System of Prostate Cancer (1/13 Tags:cancer, tumors, immune system, prostatein experiments with mice, researchers have found that the body's immune system can use a surprisingly common. e. Harnessing the Immune System to Fight Off Cancer Cells Harnessing the immune system to fight off cancer cells. Common molecule notifies immune system of prostate cancer Common molecule notifies immune system of prostate cancer. published about 18 hours ago. In experiments with mice, researchers have found that the body's Immune cell may explain breast, prostate cancer vaccine resistance Because he has identified a new type of immune cells that suppresses the ability of the immune system to fight breast and prostate cancer, Wang knows he has Immune Cells Thwart Prostate Drugs -- Unger 2006 (210): 4 Immune Cells Thwart Prostate Drugs. By Katherine Unger ScienceNOW Daily News 10 February 2006. Many men diagnosed with prostate cancer receive HHMI News: Common Molecule Notifies Immune System of Prostate Cancer Allison's research, published in the January 11, 2008, issue of Science, found that immune cells can, in fact, detect prostate cancer, at least in lab mice. Common molecule notifies immune system of prostate cancer PhysOrg news: Common molecule notifies immune system of prostate cancer. Tumor-targeted immune cells cure prostate cancer in mice without In a major breakthrough in cancer gene therapy, a Northwestern University researcher has endowed immune cells with the ability to specifically target Common molecule notifies immune system of prostate cancer In experiments with mice, researchers have found that the body's immune system can use a surprisingly common molecule to recognize prostate tumors. |
| immune prostate cancer |
|
prostate cancer alternative medicine hormone prostate cancer prostate calcifications prostate cancer in young man |